6 results
Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del #EBM #CysticFibrosis #Tezacaftor #Ivacaftor #CFTR #Phe508del #NEJM
Homozygous for Phe508del ... #EBM #CysticFibrosis ... Tezacaftor #Ivacaftor #CFTR ... #Phe508del #NEJM ... #VisualAbstract
Mortality after Fluid Bolus in African Children with Severe Infection - June 30, 2011 N Engl
NEJMoa1101549 #EBM ... #Peds #Pediatrics ... Boluses #Africa #NEJM ... #VisualAbstract
Classes of Mutations in the Gene Encoding Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). Depending on the
molecular defect, CFTR ... no functional CFTR ... #Pharm #Pathophys ... #Pulm #Peds #CysticFibrosis ... ModulatorTherapy #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Care TRICC - NEJM ... - ICU FOCUS - NEJM ... unnecessary and cause harm ... /vmoitra) #EBM ... Thresholds #Hematology #VisualAbstract
Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia #EBM #Peds #Budesonide #BronchopulmonaryDysplasia #BPD #VisualAbstract #NEJM
Bronchopulmonary Dysplasia #EBM ... #Peds #Budesonide ... BronchopulmonaryDysplasia #BPD #VisualAbstract ... #NEJM
Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis - Kupperman et al. NEJM 2018

https://www.nejm.org/doi/full/10.1056/NEJMoa1716816
Study
NEJM 2018 https ... TessaRDavis #EBM ... #VisualAbstract ... #Peds #Pediatrics ... Infusion #Rates #NEJM